Clinical trial
ITI-007 (Lumateperone Tosylate) for Schizophrenia
NCT03817528 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ITI-007 (Lumateperone Tosylate) for Schizophrenia
- Lead sponsor
- New York State Psychiatric Institute
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 1, 2019
- Completion date
- September 23, 2020
- Enrollment
- 4 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.